Back

Genotype or phenotype or both? Current risk prediction in dilated cardiomyopathy and non-dilated left ventricular cardiomyopathy

30 August 2026 (18:00 - 18:15)
Organised by: Logo
Congress Presentation Part of: Personalised risk stratification in cardiomyopathies: where are we now? Risk Factors and Risk Assessment ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Associate Professor Lia Crotti

University of Milan Bicocca, Milan (Italy)

3 More presentations in this session

Presentation thumbnail
What is the current role of cardiac magnetic resonance and clinical risk scores in risk stratification for hypertrophic cardiomyopathy?
Professor P. Elliott (London, GB)
Slides Video
Presentation thumbnail
Is the arrhythmogenic right ventricular cardiomyopathy phenotype outdated for risk prediction?
Doctor A. te Riele (Utrecht, NL)
Slides Video
Presentation thumbnail
Personalised risk stratification in cardiomyopathies: where are we now? - discussion
Video

Access the full session

Session thumbnail
Personalised risk stratification in cardiomyopathies: where are we now?
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 18:00 CET
You may be interested in
thumbnail
Congress Presentation
Non-sustained ventricular tachycardia in non-dilated left ventricular cardiomyopathy with left ventricular late enhancement: what do the guidelines say?
30 August 2024
thumbnail
Congress Presentation
The role of genetics
29 August 2026
thumbnail
Congress Presentation
Imaging risk prediction in cardiomyopathies - discussion
30 August 2026
thumbnail
Congress Presentation
Predicting risk and guiding therapy in biventricular/left-dominant arrhythmogenic cardiomyopathy
13 April 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources